alexa The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events.
Diabetes & Endocrinology

Diabetes & Endocrinology

Journal of Metabolic Syndrome

Author(s): Hjelmesaeth J, Hartmann A, Leivestad T, Holdaas H, Sagedal S,

Abstract Share this page

Abstract The impact of early-diagnosed new-onset post-transplantation diabetes mellitus (PTDM) on cardiovascular (CV) disease is not well described. The objectives of the present prospective single-center observational study were to assess the long-term effects of early-diagnosed new-onset PTDM on major cardiac events (MCE; cardiac death or nonfatal acute myocardial infarction) and patient survival. Diabetic status and CV risk factors were assessed in 201 consecutive renal allograft recipients 3 months after transplantation (baseline) during a period of 16 months (1995-96). Follow-up data until January 1, 2004 were obtained from the Norwegian Renal Registry. The 8-year (range 7-9 years) cumulative incidence of MCEs was 7\% (nine out of 138) in recipients without diabetes, 20\% (seven out of 35) in patients with new-onset PTDM and 21\% (six out of 28) in patients with diabetes mellitus before transplantation (DM). Proportional hazards regression analyses (forward stepwise regression) revealed that patients with PTDM had an approximately three-fold increased risk of MCEs as compared with nondiabetic patients (hazard ratio (HR)=3.27, 95\% confidence interval (CI)=1.22-8.80, P=0.019). A total of 61 patients (30\%) died. Eight-year patient survival was 80\% in the nondiabetic group, 63\% in the PTDM group and 29\% in the DM group, respectively. Pretransplant diabetes (HR=5.09, 95\% CI=2.60-9.96, P<0.001), age (HR=1.03, 95\% CI=1.01-1.05, P=0.016), cytomegalovirus (CMV) infection (HR=2.66, 95\% CI=1.27-5.53, P=0.009), and creatinine clearance (HR=0.98, 95\% CI=0.96-1.00, P=0.046), but not PTDM (HR=1.20, 95\% CI=0.58-2.49, P=0.621), were independent predictors of death in the multiple Cox regression model. Early-diagnosed PTDM is a predictor of MCEs, but not of all-cause mortality, the first 8 years after renal transplantation. This article was published in Kidney Int and referenced in Journal of Metabolic Syndrome

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords